Myriad Genetics

MYGN · NASDAQ

$5.54+$1.33 (+31.59%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $4.21

Latest news

NewsOct 20, 12:37 PM ETVandana Singh
Myriad Genetics Offloads Struggling Prenatal Unit for $210 Million to Labcorp
NewsOct 20, 12:01 PM ETAvi Kapoor
Nasdaq Rises Over 100 Points; 3M Earnings Top Views
NewsOct 20, 10:16 AM ETAvi Kapoor
Hasbro Posts Upbeat Q3 Earnings, Joins Myriad Genetics, Equifax And Other Big Stocks Moving Higher On Tuesday
NewsOct 20, 8:35 AM ET
Myriad Genetics To Sell Its Prenatal Health Testing Business, Including Prequel, Foresight, SneakPeek And FirstGene Tests, To Labcorp For $210M In Cash Plus Inventory Value
Press releaseOct 20, 8:30 AM ETGlobe Newswire
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
Press releaseOct 15, 4:05 PM ETGlobe Newswire
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
Press releaseOct 8, 9:00 AM ETPRNewswire
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
Press releaseSep 16, 8:00 AM ETGlobe Newswire
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
NewsSep 1, 8:02 AM ETAvi Kapoor
Cango, Nio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Press releaseAug 13, 8:00 PM ETBusiness Wire
MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Press releaseAug 10, 10:07 AM ETPRNewswire
Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky
Press releaseAug 8, 2:57 PM ETBusiness Wire
MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law
Press releaseAug 7, 2:54 PM ETGlobe Newswire
MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm
Press releaseAug 5, 8:00 PM ETGlobe Newswire
MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
Press releaseAug 5, 10:07 AM ETBusiness Wire
MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)
Press releaseAug 4, 10:07 AM ETPRNewswire
MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics
Press releaseAug 3, 6:14 PM ETPRNewswire
Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)
NewsJul 31, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsJul 31, 12:02 PM ETAvi Kapoor
Crude Oil Gains 1%; Apple Shares Tumble After Q3 Results
NewsJul 31, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsJul 31, 1:48 AM ETTanya Rawat
Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know
NewsJul 30, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseJul 30, 4:05 PM ETGlobe Newswire
Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability
NewsJul 29, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseMay 27, 9:05 AM ETGlobe Newswire
Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting
Press releaseMay 15, 11:00 AM ETGlobe Newswire
Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life
Press releaseMay 5, 4:05 PM ETGlobe Newswire
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business
Press releaseApr 16, 9:15 AM ETGlobe Newswire
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
Press releaseMar 6, 6:39 PM ETPRNewswire
Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
NewsFeb 24, 7:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseFeb 24, 7:05 AM ETBusiness Wire
Diality Appoints Peter Donato as Chief Financial Officer
Press releaseFeb 23, 4:05 PM ETGlobe Newswire
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
NewsFeb 20, 2:01 PM ET
Myriad Genetics's Earnings: A Preview
Press releaseJan 12, 8:30 AM ETGlobe Newswire
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
NewsNov 4, 12:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseNov 3, 4:05 PM ETGlobe Newswire
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
NewsOct 31, 4:01 PM ET
Exploring Myriad Genetics's Earnings Expectations
Press releaseSep 23, 8:01 AM ETPRNewswire
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Press releaseAug 20, 2:00 AM ETACCESS Newswire
ANGLE Announces Collaboration with Myriad Genetics
NewsAug 6, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 6, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsAug 6, 5:53 AM ETRishabh Mishra
Stock Market Today: US Futures Edge Higher As Investors Await Earnings From McDonald's, Uber And Walt Disney

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Myriad Genetics Offloads Struggling Prenatal Unit for $210 Million to Labcorp

Nasdaq Rises Over 100 Points; 3M Earnings Top Views

Hasbro Posts Upbeat Q3 Earnings, Joins Myriad Genetics, Equifax And Other Big Stocks Moving Higher On Tuesday

Myriad Genetics To Sell Its Prenatal Health Testing Business, Including Prequel, Foresight, SneakPeek And FirstGene Tests, To Labcorp For $210M In Cash Plus Inventory Value

Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

Cango, Nio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law

MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm

MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)

12 Health Care Stocks Moving In Friday's Intraday Session

Crude Oil Gains 1%; Apple Shares Tumble After Q3 Results

12 Health Care Stocks Moving In Friday's Pre-Market Session

Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know

12 Health Care Stocks Moving In Thursday's After-Market Session

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

12 Health Care Stocks Moving In Wednesday's After-Market Session

Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting

Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life

Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Diality Appoints Peter Donato as Chief Financial Officer

Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

Myriad Genetics's Earnings: A Preview

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance

12 Health Care Stocks Moving In Tuesday's Intraday Session

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Exploring Myriad Genetics's Earnings Expectations

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

ANGLE Announces Collaboration with Myriad Genetics

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Stock Market Today: US Futures Edge Higher As Investors Await Earnings From McDonald's, Uber And Walt Disney